Trial Profile
Phase Ib study of polyphenon E in a pre-prostatectomy prostate cancer cohort..
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Polyphenon E (Primary)
- Indications Prostate cancer
- Focus Biomarker; Therapeutic Use
- 07 Aug 2012 Primary end points added as reported by ClinicalTrials.gov record.
- 21 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov